Integra LifeSciences IART Tissue Reconstruction — Total Revenues
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's tissue reconstruction — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Integra LifeSciences's tissue reconstruction — total revenues?
- Integra LifeSciences (IART) reported tissue reconstruction — total revenues of $108.78M in Q1 2026.
- What does tissue reconstruction — total revenues mean?
- This represents the total gross sales generated by the Tissue Reconstruction business segment. It serves as a primary indicator of market demand and the segment's contribution to the company's overall top-line growth.